Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled.

Greene CM, Varley RB, Lawless MW.

World J Gastroenterol. 2013 Aug 28;19(32):5212-26. doi: 10.3748/wjg.v19.i32.5212. Review.

2.

Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma.

Gailhouste L, Ochiya T.

Histol Histopathol. 2013 Apr;28(4):437-51. doi: 10.14670/HH-28.437. Review.

PMID:
23224781
3.

Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.

Lamontagne J, Steel LF, Bouchard MJ.

World J Gastroenterol. 2015 Jun 28;21(24):7375-99. doi: 10.3748/wjg.v21.i24.7375. Review.

4.

Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.

Hou W, Bonkovsky HL.

World J Gastroenterol. 2013 Nov 28;19(44):7836-45. doi: 10.3748/wjg.v19.i44.7836. Review.

5.

MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.

He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS.

Oncogene. 2012 Jul 12;31(28):3357-69. doi: 10.1038/onc.2011.500.

PMID:
22056881
6.

Epigenetics of hepatocellular carcinoma: role of microRNA.

Khare S, Zhang Q, Ibdah JA.

World J Gastroenterol. 2013 Sep 7;19(33):5439-45. doi: 10.3748/wjg.v19.i33.5439. Review.

7.

miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression.

Chu R, Mo G, Duan Z, Huang M, Chang J, Li X, Liu P.

Cell Commun Signal. 2014 Jul 11;12:45. doi: 10.1186/s12964-014-0045-y. Review.

8.

MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target.

Hung CH, Chiu YC, Chen CH, Hu TH.

Biomed Res Int. 2014;2014:486407. doi: 10.1155/2014/486407. Review.

9.

miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.

Lian J, Jing Y, Dong Q, Huan L, Chen D, Bao C, Wang Q, Zhao F, Li J, Yao M, Qin L, Liang L, He X.

Oncotarget. 2016 Jan 19;7(3):2672-83. doi: 10.18632/oncotarget.6603.

10.

MicroRNA involvement in hepatocellular carcinoma.

Gramantieri L, Fornari F, Callegari E, Sabbioni S, Lanza G, Croce CM, Bolondi L, Negrini M.

J Cell Mol Med. 2008 Dec;12(6A):2189-204. doi: 10.1111/j.1582-4934.2008.00533.x. Review.

11.

The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment.

D'Anzeo M, Faloppi L, Scartozzi M, Giampieri R, Bianconi M, Del Prete M, Silvestris N, Cascinu S.

Molecules. 2014 May 19;19(5):6393-406. doi: 10.3390/molecules19056393. Review.

12.

MicroRNAs and liver disease: viral hepatitis, liver fibrosis and hepatocellular carcinoma.

Li G, Cai G, Li D, Yin W.

Postgrad Med J. 2014 Feb;90(1060):106-12. doi: 10.1136/postgradmedj-2013-131883. Review.

PMID:
24243965
13.

MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.

Fang F, Chang RM, Yu L, Lei X, Xiao S, Yang H, Yang LY.

J Hepatol. 2015 Oct;63(4):874-85. doi: 10.1016/j.jhep.2015.05.008.

PMID:
25998163
14.

Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma.

Borel F, Konstantinova P, Jansen PL.

J Hepatol. 2012 Jun;56(6):1371-83. doi: 10.1016/j.jhep.2011.11.026. Review.

15.

MiRNA-192 [corrected] and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma.

Ge Y, Yan X, Jin Y, Yang X, Yu X, Zhou L, Han S, Yuan Q, Yang M.

PLoS Genet. 2015 Dec 28;11(12):e1005726. doi: 10.1371/journal.pgen.1005726. Erratum in: PLoS Genet. 2016 Jan;12(1):e1005825.

16.

Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis Programs.

Selitsky SR, Dinh TA, Toth CL, Kurtz CL, Honda M, Struck BR, Kaneko S, Vickers KC, Lemon SM, Sethupathy P.

MBio. 2015 Dec 8;6(6):e01500-15. doi: 10.1128/mBio.01500-15.

17.

MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches.

Callegari E, Gramantieri L, Domenicali M, D'Abundo L, Sabbioni S, Negrini M.

Cell Death Differ. 2015 Jan;22(1):46-57. doi: 10.1038/cdd.2014.136. Review.

18.

Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma.

Law PT, Wong N.

J Gastroenterol Hepatol. 2011 Mar;26(3):437-49. doi: 10.1111/j.1440-1746.2010.06512.x. Review.

PMID:
21332540
19.

MicroRNAs involved with hepatocellular carcinoma (Review).

Mao B, Wang G.

Oncol Rep. 2015 Dec;34(6):2811-20. doi: 10.3892/or.2015.4275. Review.

PMID:
26398882
20.

Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.

Nahon P, Sutton A, Rufat P, Ziol M, Thabut G, Schischmanoff PO, Vidaud D, Charnaux N, Couvert P, Ganne-Carrie N, Trinchet JC, Gattegno L, Beaugrand M.

Gastroenterology. 2008 Jan;134(1):102-10.

PMID:
18061182

Supplemental Content

Support Center